To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Polyethyleneimine is a po… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens

Journal article
Authors F. Wegmann
K. H. Gartlan
Ali M Harandi
S. A. Brinckmann
M. Coccia
W. R. Hillson
W. L. Kok
S. Cole
L. P. Ho
T. Lambe
M. Puthia
C. Svanborg
E. M. Scherer
G. Krashias
A. Williams
J. N. Blattman
P. D. Greenberg
R. A. Flavell
A. E. Moghaddam
N. C. Sheppard
Q. J. Sattentau
Published in Nature Biotechnology
Volume 30
Issue 9
Pages 883-U116
ISSN 1087-0156
Publication year 2012
Published at Institute of Biomedicine, Department of Microbiology and Immunology
Pages 883-U116
Language en
Links dx.doi.org/10.1038/nbt.2344
Keywords antibody-responses, intranasal delivery, protective immunity, nalp3, inflammasome, dendritic cells, gene delivery, bells-palsy, vaccine, toxin, innate
Subject categories Medical Biotechnology

Abstract

Protection against mucosally transmitted infections probably requires immunity at the site of pathogen entry(1), yet there are no mucosal adjuvant formulations licensed for human use. Polyethyleneimine (PEI) represents a family of organic polycations used as nucleic acid transfection reagents in vitro and DNA vaccine delivery vehicles in vivo(2,3). Here we show that diverse PEI forms have potent mucosal adjuvant activity for viral subunit glycoprotein antigens. A single intranasal administration of influenza hemagglutinin or herpes simplex virus type-2 (HSV-2) glycoprotein D with PEI elicited robust antibody-mediated protection from an otherwise lethal infection, and was superior to existing experimental mucosal adjuvants. PEI formed nanoscale complexes with antigen, which were taken up by antigen-presenting cells in vitro and in vivo, promoted dendritic cell trafficking to draining lymph nodes and induced non-proinflammatory cytokine responses. PEI adjuvanticity required release of host double-stranded DNA that triggered Irf3-dependent signaling. PEI therefore merits further investigation as a mucosal adjuvant for human use.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?